OIG Approves Manufacturer’s Direct-to-Patient Discount Sales Program
By EsqSocial Corporation 13/08/14
The Office of Inspector General (“OIG”) recently posted an Advisory Opinion approving a pharmaceutical manufacturer’s direct-to-patient product sales program. While this Advisory Opinion cannot be relied upon by anyone other than the requestor, it...
By: Mintz Levin - Health Law & Policy Matters